Study Summary
This trial will test whether a brain stimulation treatment called transcranial Direct Current Stimulation (tDCS) can help improve walking abilities in stroke survivors when used alongside physical therapy.
- Gait Impairment
- Stroke
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: at 1-4 days after completion of 10-session intervention protocol
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Active tDCS
1 of 2
Sham tDCS
1 of 2
Active Control
Non-Treatment Group
50 Total Participants · 2 Treatment Groups
Primary Treatment: Active tDCS · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the current capacity for recruitment in this research study?
"Affirmative. Clinicaltrials.gov attests to this trial's recruitment status; initially posted on September 13th 2018 and most recently updated October 5th 2022, the study is seeking 50 participants from a single site." - Anonymous Online Contributor
Are there opportunities to enroll in this experiment currently?
"Per the clinicaltrials.gov listing, recruitment is ongoing for this medical trial that was initially published on September 13th 2018 and then modified October 5th 2022." - Anonymous Online Contributor
What hazards have been documented with regards to Active tDCS?
"While Active tDCS shows promise in terms of safety, there is currently no evidence that supports its efficacy. Our team at Power therefore assign it a score of 2 on the 1-3 scale." - Anonymous Online Contributor